3-(7-Cyano-5-(2-nitropropyl)indolin-1-yl)propyl benzoate
≥97%
- Product Code: 81017
CAS:
350797-56-7
| Molecular Weight: | 393.44 g./mol | Molecular Formula: | C₂₂H₂₃N₃O₄ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD17169997 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | Room temperature, dry and sealed |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of various bioactive molecules, particularly those targeting neurological disorders. Its structure, featuring a nitropropyl group and a cyano-substituted indoline moiety, makes it valuable for developing compounds with potential antipsychotic or neuroprotective properties. Researchers explore its derivatives for their ability to modulate neurotransmitter systems, such as dopamine or serotonin receptors, which are critical in treating conditions like schizophrenia, depression, or Parkinson's disease. Additionally, its benzoate ester group enhances its stability and bioavailability, making it a suitable candidate for further drug development and optimization.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.250 | 10-20 days | €11.87 |
+
-
|
| 1.000 | 10-20 days | €23.98 |
+
-
|
| 5.000 | 10-20 days | €57.70 |
+
-
|
3-(7-Cyano-5-(2-nitropropyl)indolin-1-yl)propyl benzoate
This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of various bioactive molecules, particularly those targeting neurological disorders. Its structure, featuring a nitropropyl group and a cyano-substituted indoline moiety, makes it valuable for developing compounds with potential antipsychotic or neuroprotective properties. Researchers explore its derivatives for their ability to modulate neurotransmitter systems, such as dopamine or serotonin receptors, which are critical in treating conditions like schizophrenia, depression, or Parkinson's disease. Additionally, its benzoate ester group enhances its stability and bioavailability, making it a suitable candidate for further drug development and optimization.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
€0.00
€0.00
Total :